Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock and derivative securities.
Summary
- On April 2, 2024, John J. Corkrean, Executive VP and CFO of H.B. Fuller, reported changes in his beneficial ownership of the company's securities.
- The report details transactions related to phantom units, employee stock options, and restricted stock units.
- Corkrean directly owns 47,187 shares of H.B. Fuller common stock.
- He also holds various employee stock options with exercise prices ranging from $43.48 to $77.72 and expiration dates between 2026 and 2034.
- Additionally, he owns restricted stock units that vest in three annual installments.
Sentiment
Score: 5
Explanation: This is a routine filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the alignment of management's interests with those of shareholders.
Stakeholder Impact
- Shareholders can use this information to understand the executive's stake in the company.
- Employees holding similar stock options or restricted stock units may be interested in the vesting schedules and exercise prices.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of grant for employee stock options exercisable until 05/17/2026 at $43.48 |
| 01/26/2018 | Date of grant for employee stock options exercisable until 01/26/2027 at $50.1 |
| 01/25/2019 | Date of grant for employee stock options exercisable until 01/25/2028 at $53.57 |
| 01/24/2020 | Date of grant for employee stock options exercisable until 01/24/2029 at $45.05 |
| 01/24/2021 | Date of grant for employee stock options exercisable until 01/24/2030 at $48.35 |
| 01/27/2022 | Date of grant for employee stock options exercisable until 01/27/2031 at $51.89 |
| 01/24/2023 | Date of grant for employee stock options exercisable until 01/24/2032 at $72.94 and restricted stock units vesting until 01/24/2025 |
| 01/24/2024 | Date of grant for employee stock options exercisable until 01/24/2033 at $68.17 and restricted stock units vesting until 01/24/2026 |
| 01/26/2025 | Date of grant for employee stock options exercisable until 01/26/2034 at $77.72 and restricted stock units vesting until 01/26/2027 |
| 04/01/2024 | Date of transaction for phantom units. |
| 04/02/2024 | Date of filing the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.